Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alitair Pharmaceuticals

Alitair Pharmaceuticals?uq=BoBgMMEs
2010 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$115K LATEST DEAL AMOUNT
Description

Developer of respiratory drugs designed to treat bronchiectasis. The company's drugs can be utilized across a range of therapeutic classes and with many different molecules for the treatment of respiratory illnesses, enabling medical professionals to treat bronchiectasis easily and patients to get relief from respiratory related diseases quickly.

Website
Formerly Known As
The Cough Company
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 55 Madison Avenue
  • Suite 400
  • Morristown, NJ 07960
  • United States

+1 (940) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alitair Pharmaceuticals’s full profile, request a free trial.

Alitair Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 09-Oct-2018 $115K 00.000 Completed Generating Revenue
3. Angel (individual) 29-Jun-2017 000 00.00 Completed Generating Revenue
2. Angel (individual) 10-Feb-2017 $100K $100K Completed Generating Revenue
1. Angel (individual) 29-Sep-2015 $911K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Alitair Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
James Hoyes Co-Chief Executive Officer & Board Member
William Howard Ph.D Co-Chief Executive Officer, President & Chairman
Helmut Albrecht MD Chief Scientific Officer
Frank Koos Senior Vice President, Business Development
Peter Wolfe Chief Financial Officer

Alitair Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
James Hoyes Alitair Pharmaceuticals Co-Chief Executive Officer & Board Member 000 0000
Robert Casale Alitair Pharmaceuticals Board Member 000 0000
William Howard Ph.D Alitair Pharmaceuticals Co-Chief Executive Officer, President & Chairman 000 0000